Media-OutReach Newswire Salmon Completes a Significantly Oversubscribed $30 Million Series A-2 Financing Round, Secures Funding from Existing Investors
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 1.